Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. (Q34169310)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

chemoradiotherapy

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

author name string

S T Martin

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

H M Heneghan

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D C Winter

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

23 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

British Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

918-928

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a single-institution experience after a median follow-up of 95 months.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Complete pathologic response after preoperative rectal cancer chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092).

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Recurrence and survival after total mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Pattern of recurrence in rectal carcinoma: implications for the design of (future) studies on adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Curative potential of multimodality therapy for locally recurrent rectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excisi

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Identifiers

10.1002/BJS.8702

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34169310&oldid=1474021456"